GlassScriptPhysician profile
Anne Panarella
NPI 1396077350
$1,470.57
in general payments reported to CMS, 2019-2025
17 companies · $42.83 in 2025
The $42.83 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $296 · 2023: $473 · 2024: $376 · 2025: $42.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $540.76 | 2021-2024 | |
| Servier Pharmaceuticals LLC | $149.68 | 2021-2024 | |
| Grifols USA, LLC | $102.63 | 2022-2024 | Thrombate III, Gamunex-C |
| Kadmon Pharmaceuticals LLC | $99.71 | 2021 | |
| Amgen INC. | $92.27 | 2021-2023 | Blincyto |
| Csl Behring | $87.16 | 2022-2024 | Hemgenix |
| Sobi, INC | $66.96 | 2021-2022 | |
| Genzyme Corporation | $59.84 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.21 | 2021-2023 | Advate |
| Alexion Pharmaceuticals, INC. | $42.19 | 2022-2024 | Ultomiris |
| Rare Disease Therapeutics, INC. | $41.32 | 2023-2025 | Purixan, Purixan |
| Octapharma USA, INC. | $29.35 | 2021 | |
| Kite Pharma, INC. | $24.75 | 2024 | Yescarta |
| Pfizer INC. | $21.82 | 2023 | |
| Bio Products Laboratory USA, INC. | $20.40 | 2023 | Coagadex, Gammaplex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.22 | 2025 | Prevymis |
| Adaptive Biotechnologies Corporation | $15.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Panarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.